Oramed Pharmaceuticals Inc
NASDAQ:ORMP
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Oramed Pharmaceuticals Inc
NASDAQ:ORMP
|
US |
|
S
|
Surapon Foods PCL
SET:SSF
|
TH |
|
Humm Group Ltd
ASX:HUM
|
AU |
|
Leroy Seafood Group ASA
OSE:LSG
|
NO |
Intrinsic Value
Is ORMP undervalued or overvalued?
See the intrinsic value estimate for Oramed Pharmaceuticals Inc and find out whether today’s valuation is cheap or expensive by its own historical standards.
Do our valuations actually work? See backtest results .
ORMP looks overvalued.
But is it expensive by its own standards?
See how today’s valuation compares with ORMP’s past valuations and how the stock performed after similar periods.
Fundamental Analysis
What Oramed Pharmaceuticals Does
Oramed Pharmaceuticals is a biopharmaceutical company that focuses on taking medicines that are usually injected and turning them into pills. Its best-known work is around oral insulin for people with diabetes, along with other oral drug delivery programs built on the same idea. The company is still mainly a development-stage business, so its value comes from its science and the medicines it is trying to bring to market rather than from a broad catalog of sold products.
- Headquarters
- United States of America US
- Employees
- 13
- IPO date
- Apr 1, 2002
Earnings Waterfall
Oramed Pharmaceuticals Inc
The intrinsic value for Oramed Pharmaceuticals Inc (ORMP) under the Base Case is hidden USD.
Compared with the current market price of 4.18 USD, the stock appears hidden.